These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2175370)
1. Renal metabolism of angiotensin I and II. Erdös EG; Skidgel RA Kidney Int Suppl; 1990 Nov; 30():S24-7. PubMed ID: 2175370 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Skidgel RA; Erdös EG Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the metabolism of substance P and neurotensin by human angiotensin I converting enzyme and "enkephalinase". Skidgel RA Prog Clin Biol Res; 1985; 192():371-8. PubMed ID: 2417254 [TBL] [Abstract][Full Text] [Related]
4. The emerging role of angiotensin-converting enzyme-2 in the kidney. Burns KD Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686 [TBL] [Abstract][Full Text] [Related]
6. A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes. Axelband F; Dias J; Miranda F; Ferrão FM; Barros NM; Carmona AK; Lara LS; Vieyra A Regul Pept; 2009 Nov; 158(1-3):47-56. PubMed ID: 19703499 [TBL] [Abstract][Full Text] [Related]
7. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Welches WR; Brosnihan KB; Ferrario CM Life Sci; 1993; 52(18):1461-80. PubMed ID: 8387132 [TBL] [Abstract][Full Text] [Related]
9. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat]. Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle. Ward PE; Russell JS; Vaghy PL Peptides; 1995; 16(6):1073-8. PubMed ID: 8532591 [TBL] [Abstract][Full Text] [Related]
11. [Role of peptidases in regulating vascular tonus]. Orekhovich VN; Eliseeva IuE; Pavlikhina LV Vestn Akad Med Nauk SSSR; 1982; (9):34-8. PubMed ID: 6128841 [No Abstract] [Full Text] [Related]
12. Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Schulz WW; Hagler HK; Buja LM; Erdös EG Lab Invest; 1988 Dec; 59(6):789-97. PubMed ID: 2848979 [TBL] [Abstract][Full Text] [Related]
13. Heme peroxidase-catalyzed iodination of human angiotensins and the effect of iodination on angiotensin converting enzyme activity. Bhuyan BJ; Mugesh G Inorg Chem; 2008 Aug; 47(15):6569-71. PubMed ID: 18598023 [TBL] [Abstract][Full Text] [Related]
14. [Properties and action specificity of carboxycathepsin (peptidyl dipepsidase) from bovine kidneys]. Eliseeva IuE; Orekhovich VN; Pavlikhina LV Vopr Med Khim; 1976; 22(1):81-9. PubMed ID: 193290 [TBL] [Abstract][Full Text] [Related]
15. Local actions of angiotensin II: quantitative in vitro autoradiographic localization of angiotensin II receptor binding and angiotensin converting enzyme in target tissues. Chai SY; Allen AM; Adam WR; Mendelsohn FA J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S35-9. PubMed ID: 2438488 [TBL] [Abstract][Full Text] [Related]
16. Renal handling of luteinizing hormone releasing hormone: a model for peptide transport and hydrolysis. Peterson DR; Skopicki HA; Zikos D; Flouret G Prog Clin Biol Res; 1988; 258():135-47. PubMed ID: 2837770 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction. Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706 [TBL] [Abstract][Full Text] [Related]
19. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 and the kidney. Soler MJ; Wysocki J; Batlle D Exp Physiol; 2008 May; 93(5):549-56. PubMed ID: 18223023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]